Earth Science Tech, Inc. (OTC: ETST) has announced its fiscal first-quarter 2027 financial results, revealing a substantial 57% year-over-year increase in net income to $715,697. The company's revenue reached $9.0 million, up 3% from the same period last year, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets grew to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001, and the company repurchased and retired over 3.7 million common shares during the quarter, all without incurring additional debt.
These results underscore the effectiveness of Earth Science Tech's diversified holding company model, which integrates compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company reported that all key operating subsidiaries remained profitable, highlighting the strength of its vertically integrated healthcare platform. Management is actively expanding the licensing footprint of its compounding pharmacy operations across the United States and evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms.
The positive financial performance comes as Earth Science Tech prepares for its annual shareholder meeting on Aug. 31, 2026. At this meeting, investors will vote on several strategic proposals, including the cancellation of the company's Series B Preferred Stock. Management will also provide updates on a potential exchange uplisting, which aims to improve liquidity and market visibility for the company's shares. This move could enhance the company's profile among investors and potentially facilitate greater access to capital markets.
The company's focus on building a seamless integration of patient care, from consultation to fulfillment, is central to its value proposition. By leveraging synergies across its specialized subsidiaries, Earth Science Tech aims to create a comprehensive healthcare experience. The company's investments in real estate and asset management activities, along with its consumer products business, provide additional support to its core healthcare operations.
For more details on the full press release, visit https://ibn.fm/WHicW. The latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST.
